Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.34 |
| ▸ | ITGAV | P06756 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | XPO1 | O14980 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.32 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10271930 | 0.97 | CES2 (0.42) | CES2IDO1GPR35ADRB1TSHR | |
| SCHEMBL16823330 | 0.97 | CES2 (0.42) | CES2IDO1GPR35ADRB1TSHR | |
| SCHEMBL16861287 | 0.97 | CES2 (0.42) | CES2IDO1GPR35ADRB1TSHR | |
| SCHEMBL15329899 | 0.97 | CES2 (0.42) | CES2IDO1GPR35ADRB1TSHR | |
| SCHEMBL26212657 | 0.88 | RAPGEF4 (0.46) | CES2IDO1MAPTRAPGEF4RXRA | |
| SCHEMBL15338946 | 0.88 | RAPGEF4 (0.46) | CES2IDO1MAPTRAPGEF4RXRA | |
| SCHEMBL16145497 | 0.86 | CYP3A4 (0.52) | IDO1TSHRALDH1A1MAPTRXRA | |
| SCHEMBL6251039 | 0.81 | TSHR (0.42) | CES2IDO1TSHRALDH1A1MAPK1 | |
| SCHEMBL440959 | 0.80 | CES2 (0.58) | CES2IDO1GPR35ADRB1TSHR | |
| SCHEMBL497733 | 0.78 | CES2 (0.41) | CES2IDO1GPR35ADRB1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260128365-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | SAMSUNG SDI CO LTD (KR) | 2026-05-07 | — | — | US | claimed |
| EP-4738511-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-06 | — | — | EP | claimed |
| US-20250074854-A1 | PROCESS FOR THE SELECTIVE CATALYTIC HYDROGENATION OF DIENONES | BASF SE (DE) | 2025-03-06 | — | — | US | claimed |
| CN-119330838-A | Method for directly heptafluoroisopropylating aromatic hydrocarbon by utilizing electron donor-acceptor compound strategy | 浙江工业大学 | 2025-01-21 | — | — | CN | claimed |
| CN-115724758-B | Camptothecin derivative intermediate, synthesis method thereof and method for synthesizing camptothecin derivative by using intermediate | 杭州中美华东制药有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119212972-A | Process for the selective catalytic hydrogenation of dienones | 巴斯夫欧洲公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119143613-A | Preparation method of 2- (3-methyl-1-methylene butyl) aniline | 浙江工业大学 | 2024-12-17 | — | — | CN | claimed |
| EP-4463433-A2 | PROCESS FOR THE SELECTIVE CATALYTIC HYDROGENATION OF DIENONES | BASF SE (DE) | 2024-11-20 | — | — | EP | claimed |
| CN-117327007-B | VT107 preparation method | 上海陶术生物科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118580135-A | Synthesis method of non-benzene type polycyclic aromatic hydrocarbon containing complex heterocyclic ring system based on metal-catalyzed coupling-cyclization reaction | 中国科学院化学研究所 | 2024-09-03 | — | — | CN | claimed |
| US-20030120006-A1 | In mold addition polymerization of norbornene-type monomers using group 10 metal complexes | THE B.F. GOODRICH COMPANY | 2003-06-26 | — | — | US | claimed |
| US-20030023013-A1 | Catalyst and methods for polymerizing cycloolefins | THE B.F.GOODRICH COMPANY | 2003-01-30 | — | — | US | claimed |
| US-20020190250-A1 | Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2002-12-19 | — | — | US | claimed |
| US-6455650-B1 | CONTACTING POLYCYCLOOLEFIN MONOMER WITH A HIGH ACTIVITY GROUP 10 TRANSITION METAL CATALYST COMPLEX TO OBTAIN POLYMER PRODUCT | THE B.F. GOODRICH COMPANY | 2002-09-24 | — | — | US | claimed |
| US-20020052454-A1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | SUMITOMO BAKELITE CO., LTD. (JP) | 2002-05-02 | — | — | US | claimed |
| US-6350832-B1 | CATALYTIC COSSLINKING POLYMER OF POLYCYCLOOLEFIN MONOMER, MOLDING AND SHAPING IN THE PRESENCE OF GROUP 10 TRANSITION METAL AND ANION | THE B. F. GOODRICH COMPANY | 2002-02-26 | — | — | US | claimed |
| EP-1155057-A1 | IN MOLD ADDITION POLYMERIZATION OF NORBORNENE-TYPE MONOMERS USING GROUP 10 METAL COMPLEXES | The B.F.Goodrich Co. (US) | 2001-11-21 | — | — | EP | claimed |
| EP-1034196-A1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | THE B.F. GOODRICH COMPANY (US) | 2000-09-13 | — | — | EP | claimed |
| WO-2000034344-A1 | IN MOLD ADDITION POLYMERIZATION OF NORBORNENE-TYPE MONOMERS USING GROUP 10 METAL COMPLEXES | THE B.F.GOODRICH COMPANY (US) | 2000-06-15 | — | — | WO | claimed |
| WO-2000020472-A1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | THE B.F. GOODRICH COMPANY (US) | 2000-04-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260128365-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | TST, SLC6A12, NCS1 | CES2 1356/4885IDO1 1973/4885GPR35 3535/4885 |
| US-20250074854-A1 | PROCESS FOR THE SELECTIVE CATALYTIC HYDROGENATION OF DIENONES | PRDX5, DHX15, NDUFS5 | CES2 1675/4885IDO1 361/4885GPR35 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.